Optimizing the Approach of Mobile Application Use to Improve Medication Adherence in Patients With Hypertension
Primary Purpose
Medication Adherence, Hypertension
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Mobile application (BP-n-Me)
Sponsored by

About this trial
This is an interventional other trial for Medication Adherence
Eligibility Criteria
Inclusion Criteria:
- 18 years of age
- Diagnosed with hypertension as evidenced by diagnosis codes or chart documentation
- Prescribed at least one antihypertensive for a minimum of three months prior to enrollment
- Have access to an Android mobile device with data capabilities
- Consent to using the application on their device
Exclusion Criteria:
- Do not read or speak English
- Unable to read and sign the informed consent or Health Insurance Privacy and Accountability Act (HIPAA) waiver
- Too ill or cognitively impaired to participate
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Other
Arm Label
Control
Intervention
Arm Description
Mobile application intervention
Outcomes
Primary Outcome Measures
Medication adherence
This was assessed based on cumulative medication gap (CMG)
Blood pressure
This was assessed by measuring the change of systolic and diastolic blood pressure
Secondary Outcome Measures
Full Information
NCT ID
NCT04066010
First Posted
August 21, 2019
Last Updated
August 28, 2019
Sponsor
Mercer University
Collaborators
Emory Healthcare, Grady Health System, Atlanta Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT04066010
Brief Title
Optimizing the Approach of Mobile Application Use to Improve Medication Adherence in Patients With Hypertension
Official Title
Optimizing the Approach of Mobile Application Use to Improve Medication Adherence in Patients With Hypertension
Study Type
Interventional
2. Study Status
Record Verification Date
August 2019
Overall Recruitment Status
Completed
Study Start Date
October 2016 (Actual)
Primary Completion Date
May 2018 (Actual)
Study Completion Date
November 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Mercer University
Collaborators
Emory Healthcare, Grady Health System, Atlanta Medical Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study was to determine the effectiveness of using a custom-designed mobile application to improve blood pressure (BP) and promote adherence to antihypertensive medication regimens. This was a prospective, multicenter, randomized controlled trial. Patients were randomized to an intervention or control group for three months. Antihypertensive medication refill history was assessed three months before, during and three months after the study period. Continuous outcome measures investigated were systolic/diastolic BP and medication refill history, using the cumulative medication gap (CMG) score.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Medication Adherence, Hypertension
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
55 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Control
Arm Type
No Intervention
Arm Title
Intervention
Arm Type
Other
Arm Description
Mobile application intervention
Intervention Type
Other
Intervention Name(s)
Mobile application (BP-n-Me)
Intervention Description
The mobile app consisted of a series of features including (1) calendar reminders of when to take medications and the patient's antihypertensive medication regimen (2) a "Call your Pharmacist" button specific to patient's pharmacy, (3) a BP log in which the patient could enter blood pressure values that were automatically compared to goal values, (4) counseling points for lifestyle and adherence factors individually tailored to each patient and (5) lifestyle and medication adherence surveys.
Primary Outcome Measure Information:
Title
Medication adherence
Description
This was assessed based on cumulative medication gap (CMG)
Time Frame
6 months
Title
Blood pressure
Description
This was assessed by measuring the change of systolic and diastolic blood pressure
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
18 years of age
Diagnosed with hypertension as evidenced by diagnosis codes or chart documentation
Prescribed at least one antihypertensive for a minimum of three months prior to enrollment
Have access to an Android mobile device with data capabilities
Consent to using the application on their device
Exclusion Criteria:
Do not read or speak English
Unable to read and sign the informed consent or Health Insurance Privacy and Accountability Act (HIPAA) waiver
Too ill or cognitively impaired to participate
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
33769555
Citation
Palmer MJ, Machiyama K, Woodd S, Gubijev A, Barnard S, Russell S, Perel P, Free C. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults. Cochrane Database Syst Rev. 2021 Mar 26;3(3):CD012675. doi: 10.1002/14651858.CD012675.pub3.
Results Reference
derived
Learn more about this trial
Optimizing the Approach of Mobile Application Use to Improve Medication Adherence in Patients With Hypertension
We'll reach out to this number within 24 hrs